Impact of bilateral versus unilateral mastectomy on short term outcomes and adjuvant therapy, 2003-2010: A report from the National Cancer Data Base

Annals of Surgical Oncology

Volumn 21, Issue 9, 2014, Pages 2920-2927

  Sharpe, Susan M ^a   Liederbach, Erik ^b   Czechura, Tomasz ^b   Pesce, Catherine ^b   Winchester, David J ^b   Yao, Katharine ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILATERAL MASTECTOMY; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; COMMUNITY HOSPITAL; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEALTH INSURANCE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MASTECTOMY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; RACE; SHORT COURSE THERAPY; SURGICAL MORTALITY; SURGICAL PATIENT; UNILATERAL MASTECTOMY; VERY ELDERLY; YOUNG ADULT; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST NEOPLASMS; BREAST RECONSTRUCTION; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; ELECTIVE SURGERY; FOLLOW UP; MORTALITY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TUMOR INVASION; UTILIZATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; ELECTIVE SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MAMMAPLASTY; MASTECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; YOUNG ADULT;

EID: 84906217232     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3687-5     Document Type: Article

References (22)

1. Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010;17:2554-62.
2. Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;33:5203-9. (Pubitemid 350232251)
3. Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697-704.
4. King TA, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29:2158-64.
5. Osman F, Saleh F, Jackson TD, Corrigan MA, Cil T. Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database. Ann Surg Oncol. 2013;20:3212-7. DOI: 10.1245/s10434-013-3116-1.
6. Miller ME, Czechura T, Martz B, Hall ME, Pesce C, Jaskowiak N, et al. Operative risks associated with contralateral prophylactic mastectomy: a single institution experience. Ann Surg Oncol. 2013;20:4113-20. DOI: 10.1245/s10434-013-3108-1.
7. Crosby MA, Garvey PB, Selber JC, Adelman DM, Sacks JM, Villa MT, et al. Reconstructive outcomes in patients undergoing contralateral prophylactic mastectomy. Plast Reconstr Surg. 2011;128:1025-33.
8. Bleicher RJ, Ruth K, Sigurdson ER, Ross E, Wong YN, Patel SA, et al. Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol. 2012;30:4485-92.
9. Bilimoria KY, Ko CY, Tomlinson JS, Stewart AK, Talamonti MS, Hynes DL, et al. Wait times for cancer surgery in the United States: Trends and predictors of delays. Ann Surg. 2011;253:779-85.
10. Wagner JL, Warneke CL, Mittendorf EA, Bedrosian I, Babiera GV, Kuerer HM, et al. Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg. 2011;254:119-24.
11. Katipumula R, Degnim AC, Hoskin T, Boughey JC, Loprinzi C, Grant CS, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009;27:4082-8.
12. Bleicher RJ, Ciocca RM, Egleston BL, Sesa L, Evers K, Sigurdson ER, et al. Association of routine pretreatment MRI with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209:180-7.
13. Hulvat M, Sandalow N, Rademaker A, Helenowski I, Hansen NM. Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging. Surgery. 2010;148:746-51.
14. Sisco M, Du H, Warner JP, Howard MA, Winchester DP, Yao K. Have we expanded the equitable delivery of postmastectomy breast reconstruction in the new millennium? Evidence from the National Cancer Data Base. J Am Coll Surg. 2012;215:658-67.
15. Landercasper J, Linebarger JH, Ellis RL, Mathiason MA, Johnson JM, Marcou KA, et al. A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg. 2010;210:449-55.
16. Desch CE, McNiff KK, Schneider EC, Schrag D, McClure J, Lepisto E, et al. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol. 2008;26:3631-7.
17. Lohrisch C, Paltiel C, Gelmon K, Spears C, Taylor S, Barnett J, et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2006;24:4888-94. (Pubitemid 46630916)
18. Colleoni M, Bonetti M, Coates AS, Castiglione-Gertsch M, Gelber RD, Price K, et al. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. J Clin Oncol. 2000;18:584-90.
19. Benk V, Joseph L, Fortin P, Zhang G, Belisle P, Levinton C, et al. Effect of delay in initiating radiotherapy for patients with early stage breast cancer. J Clin Oncol. 2004;16:6-11. (Pubitemid 38195863)
20. Jones RVH, Greenwood B. Breast cancer: causes of patients' distress identified by qualitative analysis. Br J Gen Pract. 1994;44:370-1. (Pubitemid 24243667)
21. Lai JK, Martin MA, Meyricke R, O'Neill T, Roberts S. Factors associated with short-term hospital readmission rates for breast cancer patients in Western Australia: an observational study. J Am Coll Surg. 2007;204:193-200. (Pubitemid 46124050)
22. Rosenberg SM, Tracy MS, Meyer ME, Sepucha K, Gelber S, Hirshfield-Bartek J, et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer. Ann Intern Med. 2013;159:373-81.